22 results on '"Nuber N"'
Search Results
2. MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma
3. Rational development of high-affinity T-cell receptor-like antibodies (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 14, (5784-5788) DOI: 10.1073/pnas.0901425106)
4. Rational development of high-affinity T-cell receptor-like antibodies (vol 106, pg 5784, 2009)
5. NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma
6. In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development
7. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients
8. Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients
9. Tumor antigen-encoding mRNA for the analysis of spontaneousand vaccine-induced immune responses in cancer patients
10. Darstellung von Chloro-aqua-Komplexen des Indium(III) und Röntgenstrukturanalyse von [InCl4(H2O)2][S4N3] - einem Tetrachloro-cis-diaqua-Komplex des Indium(III).
11. MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients.
12. Yeast-based identification of prostate tumor antigens provides an effective vaccine platform
13. Darstellung von Chloro‐aqua‐Komplexen des Indium(III) und Röntgenstrukturanalyse von [InCl4(H2O)2][S4N3] – einem Tetrachloro‐cis‐diaqua‐Komplex des Indium(III)
14. Opportunities and Challenges in Developing a Cryptosporidium Controlled Human Infection Model for Testing Antiparasitic Agents.
15. The development of autoimmune features in aging mice is closely associated with alterations of the peripheral CD4⁺ T-cell compartment.
16. NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.
17. A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.
18. Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
19. Yeast-based identification of prostate tumor antigens provides an effective vaccine platform.
20. Rational development of high-affinity T-cell receptor-like antibodies.
21. Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients.
22. Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.